Dose MACRO ENVY Macrodose Psilocybin Capsules is offered to provide an exceptionally euphoric, distinctly visual, and profoundly introspective mushroom experience. This special blend comprises 450mg Organic Albino Penis Envy (Psilocybe cubensis) in a potent 500mg capsule dose extracted only from the fruiting bodies of this rare and extremely difficult t harvest posilocybin mushroom. In addition, 50mg of organic peppermint (Mentha Piperita) has been added as a soothing agent for potential digestive upsets while decreasing instances of nausea, or headaches. Each bottle contains 15 capsules – Vegan friendly and Gluten-Free.
Recommended use: Promotes increased positivity in mood, mindfulness, Introspective insights, self-efficacy, flow states, enhanced meditation, and alleviation of some adverse conditions relating to addiction, depression, anxiety, chronic pain, OCD, ADD/ADHD, and PTSD.
- Psilocybe cubensis (Albino Penis Envy) – 450mg
- Organic Peppermint (Mentha Piperita) – 50mg
- Reported as having the highest concentration of Psilocin/Psilocybin within the p.cubensis family. Psilocin contained in Albino Penis Envy will illicit quick activation as it passes the blood-brain barrier at a faster rate than waiting for the body to metabolize the psilocybin into Psilocin (the psychoactive ingredient in magic mushrooms)
- Provides the ability to achieve the upper limits of the psychedelic dosing spectrum while consuming less. Effects may be felt within 15-30 minutes of consuming with peak activation within 1-2 hours and lasting up to 6 hours.
- Harvested only from the fruiting bodies of the psilocybin mushroom. No added fillers such as starch, grains or mycelium
- Non-GMO, Vegan Friendly + Gluten Free
- 500mg capsule
- 15 capsules per bottle
Each bottle contains 15 capsules. Each capsule is 500mg (450mg of Albino Penis Envy (Psilocybe Cubensis), and 50mg of Organic Peppermint (Mentha Piperita)). Dose MACRO ENVY Macrodose Psilocybin Capsules
The benefits of full-dose psychedelics
While more than a thousand early studies linked psychedelic use with beneficial effects , there was a 40-year pause on psychedelic research following the prohibition of these substances . Despite continued prohibition, modern research has revealed the promising potential of LSD and psilocybin for treating alcohol and tobacco dependence [14,15,16,17], depression [18, 19], and end-of-life anxiety [20,21,22], while related research on 3,4-methylenedioxymethamphetamine (MDMA) has shown great promise for treating post-traumatic stress disorder . Psychedelics can also increase openness and occasion mystical-type experiences in healthy controls [24,25,26]. As full-dose psychedelics appear to aide in the relief of severe, chronic psychiatric conditions (e.g. depression, anxiety, PTSD), milder mental health concerns may plausibly be treated by lower, recurring doses. This is especially worth considering if certain full-dose outcomes are found to rely on purely pharmacologic mechanisms rather than primarily on phenomenological experiences .
Limiting microdosing research to topics that have been investigated in full-dose research could prematurely overlook unpredicted and potentially distinct microdosing outcomes. Full-dose research has employed various focal assessments of symptomatology, mood, and personality that are likely applicable to microdosing research, but due to the low doses and lack of perceptual alteration intended in microdosing, other full-dose phenomena, such as ego dissolution and mystical-type experiences, are less relevant to microdosing research. Instead, as a means of preparing for a broad range of outcomes, the present work solicited open-ended reports of benefits and challenges. Additionally, as psychedelic substances act on distinct yet overlapping neural receptor sites, it seems plausible that distinct patterns could emerge for different substances. The present study thus included microdosers who used LSD, psilocybin, or both.
Free Expedited Shipping on orders over $250
We ship worldwide with tracking number
Discreet and vacuum sealed packaging for your privacy